14 research outputs found
Blood chemistry changes in broiler chickens following supplementation with Cinnamomum zeylanicum
A study was conducted to investigate the effects of different doses of Cinnamomum zeylanicum in diet on blood biochemistry of broiler chickens. Thirty two, 1-d old male broiler chickens of a commercial strain ROSS 308 were distributed into groups of 8 birds in each one. The chicks received the diets from the day of hatching to 38 d of age. The four types of diets included basal diets for chicks (HYD 01, HYD 02 and HYD 03) supplemented by 0%, 0.1%, 0.05 and 0.025% cinnamon (Cinnamomi aetheroleum of Cinnamomum zeylanicum, Calendula a.s., Novå L'ubovña, Slovakia). Continuous lighting and water and feed ad libitum were provided throughout the trial. The addition of cinnamon to the diets caused a significantly lower plasma glucose level and the effects of cinnamon on plasma glucose levels tended to be dose-dependent. Dietary intake of 0.05 and 0.025% cinnamon reduced serum ALT and plasma potassium levels. Ingestion of cinnamon, however, resulted in no significant changes in circulating calcium, albumin, triglycerides, free glycerol and cholesterol levels. It was concluded that cinnamon could be used not only for flavor and taste in food preparation but it had an additional role in glucose metabolism in broiler chickens
Evaluacija uticaja esencijalnog ulja salvia officinalis na biohemijske vrednosti u plazmi, sluznicu creva i kvantitet kiselih i neutralnih mucina u crevima piliÄa
AbstractIn this study the effects of Salvia officinalis L. essential oil on the thickness of the gut mucus layer and quantity of neutral and acidic mucins in chickens were observed. Oneday-old chickens of Isa Brown breed were divided into five groups (n = 9) and fed 11 weeks as follows: control group (C): basal diet; experimental groups (E1 - E4) - same as C + sage essential oil (EO) in concentrations of 0.01%; 0.025%; 0.05% and 0.1%, respectively. The thickness of the mucus layer in the duodenum significantly increased in E3(0.05% sage EO) compared to E1 (0.01 % sage EO). In E3 (0.05% sage EO) the number of goblet cells containing acidic and neutral mucins was significantly decreased in the duodenum and jejunum and increased in the ileum compared to C. Feeding the diet supplemented with Se and 0.01% sage EO (E1) decreased plasma cholesterol level in comparison with E3(0.05 % sage EO). The addition of 0.05% (E3) and 0.1% sage EO (E4) to the diet caused a decrease in calcium plasma level compared to E2 (0.025 % sage EO). Plasma glucose level was significantly decreased in groups fed 0.05% (E3) and 0.025% sage EO (E2) compared with 0.01% sageStudija se odnosi na posmatranje efekata Salvia offi cinalis L. esencijalnih ulja na debljinu sluznice creva i kvantitet neutralnih i kiselih mucina kod piliÄa. Formirano je pet grupa sa po 9 jednodnevnih piliÄa rase Isa Brown koji su u narednih 11 nedelja hranjeni na sledeÄi naÄin: kontrolna (C) grupa je dobijala osnovni obrok sa dodatkom Na selenita (Se) u koncentraciji 0,04 ppm + suncokretovo ulje (1%); eksperimentalne grupe E1 do E4: isto kao C grupa uz dodatak esencijalnog ulja ĆŸalfi je (EO) u koncentraciji 0,01%, 0,025; 0,05% odnosno 0,1%. Debljina sloja mukusa u duodenumu je znaÄajno porasla kod piliÄa E3 grupe (Se i 0,05% EO ulja) u poreÄenju sa E1 grupom (Se i 0,01% EO ulja). U E3 grupi (Se i 0,05% EO ulja) broj peharastih Äelija koje sadrĆŸe kisele i neutralne mucine je znaÄajno bio smanjen u duodenumu i jejunumu, a poveÄan u ileumu u poreÄenju sa C grupom. Ishrana sa dodatkom Se i 0,01% EO ulja ĆŸalfi je (E1) izazivala je smanjenje koncentracije holesterola u plazmi u poreÄenju sa E3 (Se i 0,05% EO ĆŸalfi je). Dodavanje Se i 0,05% EO ĆŸalfi je (E3) kao i 0.1% EO ulja (E4) izazvalo je smanjenje koncentracije kalcijuma u plazmi u poreÄenju sa E2 (Se i 0,025% EO ulja). Koncentracije glukoze u plazmi su znaÄajno bile smanjene u grupama koje su dobijale Se i 0,05% (E3) i 0,025% EO (E2) ulja ĆŸalfi je, u poreÄenju sa E1 grupom (0,01% EO ulja). RazliÄiti sastavi obroka po grupama nisu imali uticaja na mase unutraĆĄnjih organa piliÄa u ogledu. Rezultati ukazuju da efekat EO ĆŸalfi je na dinamiku adherencije sloja mukusa kao i na tip i distribuciju mucina u crevima piliÄa zavisi od doze EO kao i od segmenta creva uz istovremeno postojanje potrebe da se obave dalja ispitivanja u cilju detaljnog objaĆĄnjenja ovog uticaja
The urinary excretion of selenium in sheep treated with a vasopressin analogue
The renal excretion of selenium was investigated in ewes with an excretion of hypotonic
urine (control group) and in ewes with a formation of highly concentrated urine.
Chronic stimulation of the urinary concentrating activity of sheep kidneys was induced
by a long-term treatment with 1-desamino-8-D-arginine vasopressin (dDAVP), a synthetic
analogue of vasopressin with prolonged effects. Young animals with 22 to 25 kg b.w.
were fed a normal protein diet providing a daily intake of 129.25 g of crude protein,
12.03 MJ of digestible energy and 0.18 mg of selenium for 3 weeks. The vasopressin
treated sheep () were given subcutaneous injections of 12.5 g of dDAVP in
glycerol twice daily for one week before the clearance measurement of renal functions.
The control group () was treated with glycerol only. The administration of dDAVP
resulted in a highly significant decrease of the urinary flow rate (from 3.19 0.50 in
control group to 0.33 0.03 mLmin in dDAVP animals, ) without changes in the
glomerular filtration rate (80.18 6.36 in controls vs. 77.86 6.26 mLmin, NS). No
effects on plasma selenium level were observed (0.17 0.03 in controls vs. 0.20 0.03
molL, NS) but the amounts of selenium excreted were found to be highly significantly
reduced (from 0.29 0.05 in controls to 0.03 0.01 nmolmin, ) in dDAVP
treated sheep. Despite a large reduction in urinary flow rate, the selenium concentration
in urine was actually the same in both groups (0.09 0.01 molL) resulting in a sharp
fall in the renal clearance of selenium (2.20 0.54 in controls vs. 0.18 0.03
mLmin, ) due to dDAVP. This seems to be a consequence of the large increase in
the selenium solvent drag induced by a vasopressin treatment. The results presented
suggest that vasopressin may contribute to maintenance of the selenium balance in sheep via
its effects on renal function.Excrétion urinaire de sélénium chez le mouton traité avec un analogue de la vasopressine.
L'excrétion rénale du sélénium a été mesurée chez des brebis produisant des urines
hypotoniques (groupe témoin) et des urines trÚs concentrées. La stimulation chronique de
l'activité rénale de concentration urinaire a été obtenue par traitement à long terme avec
de la 1-désamino-8-D-arginine vasopressine (dDAVP), un analogue synthétique de la
vasopressine aux effets prolongés. Des jeunes brebis (22 à 25 kg poids vif) ont été
nourries avec un régime normoprotéique (protéine brute = 129,25 g ;
énergie digestible = 12,03 MJ et sélénium = 0,18 mg par jour) pendant trois semaines.
Les brebis traitées () ont reçu une solution de glycérol contenant 12,5 g de
dDAVP par voie sous-cutanée, deux fois par jour pendant une semaine, juste avant les
mesures de clairance rénale. Le groupe témoin () a reçu du glycérol seul.
L'administration de dDAVP a induit une réduction trÚs significative de la diurÚse
(de 3,19 0,50 chez les témoins à 0,33 0,03 mLmin, ) sans modifier
le débit de filtration glomérulaire (80,18 6,36 chez les témoins contre
77,86 6,26 mLmin, NS). Le niveau plasmatique de sélénium n'a pas été
modifié par l'administration de dDAVP (0,17 0,03 chez les témoins contre
0,20 0,03 molL, NS), mais la quantité de sélénium éliminée a été trÚs
significativement réduite (de 0,29 0,05 chez les témoins à 0,03 0,01
nmolmin chez le groupe traité, ). Malgré la chute de la diurÚse,
la concentration urinaire de sélénium n'a pas varié sous dDAVP (0,09 0,01 molL
chez les deux groupes) et, de ce fait, la clairance rénale du sélénium s'est vue
fortement diminuée (2,20 0,54 chez les témoins contre 0,18 0,03 mLmin, ).
Ceci peut ĂȘtre attribuĂ© Ă une augmentation du phĂ©nomĂšne de drainage par le solvant Ă la
suite du traitement avec dDAVP. Ces résultats suggÚrent que la vasopressine peut
contribuer à la régulation du bilan de sélénium chez le mouton, par le biais de ses
effets sur la fonction rénale
Effects of feeding diets contaminated with Fusarium mycotoxins on blood biochemical parameters of broiler chickens
This study was conducted to investigate the effects of deoxynivalenol (DON) and zearalenone (ZEA) on some biochemical indices of broiler chickens. Twenty-four Ross 308 hybrid broiler chickens of both sexes were fed diets containing maize contaminated with
Fusarium
mycotoxins. The diets included a control diet (DON 0.60 mg/kg feed; ZEA 0.07 mg/kg feed), an experimental 1 diet (DON 3.4 mg kg feed; ZEA 3.4 mg kgâ1 feed), and an experimental 2 diet (DON 8.2 mg kgâ1 feed; ZEA 8.3 mg kgâ1
feed). Contaminated diets were fed from 14 days of age for 14 days. Blood samples were collected from 4-week-old birds. Chicks fed a diet containing a low level of contaminated maize (experimental 1) had decreased plasma potassium, magnesium, phosphorus, total protein, albumin, triglycerides, free glycerol concentrations and increased cholesterol and calcium levels as well as alkaline phosphatase (ALP) and aspartate aminotransferase (AST) enzyme activities as compared to the control. Feeding a diet contaminated with high levels of mycotoxins (experimental 2) resulted in decreased plasma potassium, magnesium, total protein, albumin, triglycerides, free glycerol concentrations and increased plasma ALP, alanine aminotransferase (ALT) and AST enzyme activities. The effect of mycotoxin-contaminated diets on ALP activity was dose dependent. Chloride concentration was not affected by the diets. It can be concluded that feeding diets contaminated with both levels of
Fusarium
mycotoxins significantly affected protein, lipid and mineral metabolism as well as AST and ALP enzyme activities in broiler chickens
Urinary selenium excretion in selenite-loaded sheep and subsequent Se dynamics in blood constituents
Renal selenium excretion in sheep was measured during intravenous infusion of sodium selenite, and the post-infusion dynamics of Se levels in whole blood, plasma and red blood cells (RBC) were investigated for the next 5 days. The plasma Se level increased almost twenty fold with the infusion of NaSeO (from to molL, ) compared with the baseline value. The selenium concentration in urine ( vs. molL, ), the amount of Se excreted ( vs. Â nmolmin, ) and the renal clearance of Se ( vs. Â mLmin, ) were found to be highly significantly elevated during selenite loading. The clearance measurements showed no changes in the urinary flow rate or in the glomerular filtration rate. During and at the end of infusion the highest Se level was attained in plasma, followed by whole blood and RBC. The plasma Se level fell rapidly within 10Â min after the end of infusion, but the concentration of Se in RBC was stable up to the fourth hour, when it started to decrease too. On day 5 the Se concentrations in plasma, RBC and whole blood were found to be only slightly but still significantly higher than before the selenite infusion. The large disproportion between the infusion rate of Se (8.76Â gmin) and its renal excretion rate (1.69Â gmin) found in clearance measurements suggests low glomerular filtration of infused selenium, which might primarily be caused by the binding of selenite metabolites to blood constituents. The presented results confirm the low bioavailability to ruminants of Se from sodium selenite